Lords Mark Industries Ltd (LORDSMARK) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Lords Mark Industries Ltd on NSE and BSE, with an AI summary of each filing.
Dr. Sachidanand Upadhyay , MD has featured in TIME magazine for third consecutive years .
Others (Uncategorized) · 03 Nov 2026, 2:13 pm
Lord’s Mark Industries MD Featured in TIME Magazine; Expands MedTech Footprint Lord’s Mark Industries announced that Founder, MD & CEO Dr. Sachidanand Upadhyay has been featured in TIME Magazine for the third consecutive year ('24, '25, and '26 editions). The company is expanding its MedTech and diagnostics presence globally, securing UK MHRA registrations for its AI-enabled haemodialysis system and IVD portfolio, alongside US FDA registration for over 200 surgical and hygiene products. Additional initiatives include a manufacturing licence for its Biomescan SaMD platform, defence technology developments, and an infrastructure partnership across 28 Caribbean nations.
Regulation 30 intimation
Others (Uncategorized) · 30 Oct 2026, 2:12 pm
Lord’s Mark Industries Showcases Indigenous Defence Portfolio for Global Expansion Lord’s Mark Industries announced the global expansion of its defence unit, Brahamastra Defence Techno Products, following three years of R&D. The company unveiled key optoelectronic innovations, including the BRAK RT long-range laser rangefinder (up to 20,000-metre range), BRAK Alpha multipurpose rangefinder, and TRC-1 Smart Trail Camera. The strategic expansion targets India’s military electro-optics and infrared market, projected to reach US$1.78 billion by 2030 (10.4% CAGR), and the global market, estimated to reach US$10.77 billion by 2031, positioning the company for international export opportunities.
Accepting Loan from Mr. Sachidanand Upadhyay , Managing Director and Promoter and approval for conducting Postal ballot
Outcome · 23 Oct 2026, 9:19 pm
Lord's Mark Industries Approves Up to Rs 100 Crore Convertible Promoter Loan Lord's Mark Industries' Board approved raising an unsecured loan of up to Rs 100 crore from Promoter and Managing Director Sachidanand H. Upadhyay, carrying an option to convert the debt into fully paid-up equity shares. Key terms—including interest rate, repayment tenure, and conversion pricing guidelines—remain subject to shareholder approval under Section 62(3) and SEBI LODR rules. The company is conducting a postal ballot via remote e-voting from 27th Oct'26 to 25th Nov'26, with final results scheduled for declaration on or before 27th Nov'26.
Silvassa manufacturing expansion completed
Others (Uncategorized) · 23 Oct 2026, 2:10 pm
Lord’s Mark Secures US FDA Registration; Expands Exports Ahead of Schedule Lord’s Mark Industries has become Asia’s first company to secure US FDA registration for over 200 surgical, medical-care, and hygiene products. The company completed its Silvassa manufacturing capacity expansion ahead of schedule and plans to commence US exports in Dec'26, while also exploring expansion across South America. The diversified portfolio includes orthopaedic supports, mobility aids, and hygiene essentials. This expansion targets high-growth markets, with the US general surgical devices market projected to reach US$9.67 billion by 2031 at a 6.35% CAGR.
Lords Mark Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve BM to consider and approve ....
Intimation · 20 Oct 2026, 3:20 am
Lord's Mark Industries Board to Consider ₹100 Crore Convertible Loan on 23rd Oct'26 Lord's Mark Industries Limited has scheduled a Board of Directors meeting on 23rd Oct'26 to evaluate and approve raising an unsecured loan of ₹100 Crore from promoter and director Sachidanand H Upadhyay. The proposed facility includes an option to convert the debt into equity shares on mutually agreed terms, subject to requisite shareholder approvals.
Appointment of CS
Change in Management · 14 Oct 2026, 11:51 pm
Lord’s Mark Industries Appoints Foram Bhuva as Company Secretary and Compliance Officer Lord’s Mark Industries Limited approved the appointment of Ms. Foram Bhuva as Whole-Time Company Secretary (Key Managerial Personnel) and Compliance Officer, effective 14th Oct'26, pursuant to Section 203 of the Companies Act, 2013 and SEBI LODR Regulations. Ms. Bhuva is an Associate Member of the Institute of Company Secretaries of India (ICSI Membership No.: A60689) with over 7.5 years of professional experience across corporate secretarial functions, SEBI listing compliances, ROC filings, and legal governance for listed and unlisted entities.
Acquisition Intimation
Others (Uncategorized) · 12 Oct 2026, 11:29 pm
Lord’s Mark Industries Acquires 100% Stake in Radio Electric for Rs 4.50 Crore Lord’s Mark Industries Limited completed the 100% equity acquisition of Radio Electric Private Limited, owner of the 'Radiotone' brand, for an all-cash consideration of Rs 4.50 Cr on 12th Oct'26. Radio Electric is a profitable, debt-free manufacturer of specialised transformers and power-control solutions serving 40–50 blue-chip domestic clients and seven export markets. Operating at ~50% single-shift capacity, the acquisition provides immediate headroom to scale production, strengthens capabilities in battery energy storage systems (BESS), and supports in-house component manufacturing for medical devices without heavy upfront capex.
Intimation for acquisition of Radiotone.
Others (Uncategorized) · 12 Oct 2026, 2:11 pm
Lord’s Mark Industries Acquires Radio Electric to Expand Transformer Manufacturing Lord’s Mark Industries Limited has acquired Radio Electric Private Limited, owner of the Radiotone brand, under its Lighting & Energy Division. The debt-free, profitable target manufactures variable autotransformers and toroidal transformers, serving 40–50 blue-chip clients, including Siemens and L&T, across seven export markets. Operating at ~50% single-shift capacity, the acquisition provides immediate production headroom without major capex. The deal bolsters Lord’s Mark's technical capabilities in Battery Energy Storage Systems and medical device component manufacturing, targeting future revenue expansion into hundreds of crores.
Update regarding MHRA Registration for IVD portfolio..
Others (Uncategorized) · 05 Oct 2026, 2:10 pm
Lord’s Mark Industries Secures UK MHRA Registration for In Vitro Diagnostics Portfolio Lord’s Mark Industries Limited received UK MHRA registration on 24th Sep'26 for its in vitro diagnostics (IVD) portfolio, covering haematological cell analysers, clinical chemistry analysers, buffered diluents, and cleaning agents. Commercial sales in the UK are slated to begin in Dec'26, two months ahead of schedule, with further expansion targeted across UK-allied markets. Additionally, the company plans to commence UK pathology laboratory operations in Jan'27, transitioning toward an integrated healthcare delivery model following its recent registration of the AI-powered Renalyx haemodialysis system.
Re-investment of funds received from sale of 89,98,598 Equity shares by Promoter Mr. Sachidanand Hariram Upadhyay for Medical Device Unit Expansion of the company.
Others (Uncategorized) · 01 Oct 2026, 8:35 pm
Lord’s Mark Industries Promoter to Reinvest Share Sale Proceeds into Medical Device Unit Lord’s Mark Industries promoter, Mr. Sachidanand Hariram Upadhyay, has proposed reinvesting the majority of proceeds from his recent stake sale into the strategic expansion of the company’s medical device unit. On 29th Sep'26, the promoter offloaded 89,98,598 equity shares via open market transactions on the BSE, realizing net proceeds of Rs 76.18 cr. The proposed capital infusion will be executed through viable and acceptable means to drive growth in the company's medical device business.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanant Upadhyay
Acquisition/ Disposal of Shares · 01 Oct 2026, 3:58 pm
Promoter Sachidanand Upadhyay Trims Stake in Lord’s Mark Industries via Open Market Lord's Mark Industries promoter Sachidanand Hariram Upadhyay sold 89,98,598 equity shares (a 2.11% stake) via open market on 29th Sep'26. Following this transaction, Upadhyay's shareholding in the company decreased from 32,04,39,246 equity shares (75.11%) to 31,14,40,648 equity shares (73.00%) of the total voting and diluted capital. The total equity base remained unchanged at 42,66,22,217 equity shares of Rs. 10 each, aggregating to Rs. 426.62 crore.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanand Upadhyay
Acquisition/ Disposal of Shares · 01 Oct 2026, 3:47 pm
Promoter Sachidanand Upadhyay Trims Stake in Lords Mark Industries Lords Mark Industries promoter Sachidanand Hariram Upadhyay offloaded 8,998,598 equity shares, representing a 2.11% stake in the company, via open market transactions on 29th Sep'26. Following this disposal, the promoter's holding decreased from 320,439,246 equity shares (75.11%) to 311,440,648 equity shares (73.00%) of the total voting and diluted share capital. The total equity capital remains unchanged at 426,622,217 shares of Rs. 10 each.
Achieved MPS of 25%
Others (Uncategorized) · 01 Oct 2026, 4:13 am
Lord's Mark Industries Achieves Minimum Public Shareholding Compliance of 25% Lord's Mark Industries Limited announced that it has successfully complied with the Minimum Public Shareholding (MPS) requirement of 25%, as mandated under SEBI Listing Regulations and the Securities Contracts (Regulation) Rules, 1957. The compliance threshold was achieved following the offloading of 1,03,56,983 equity shares on 18th Sep'26 and an additional 89,98,598 equity shares on 29th Sep'26. Consequently, the company has fulfilled Regulation 38 requirements regarding minimum public float.
Voting results and Scrutinizer report
Annual General Meeting · 01 Oct 2026, 4:09 am
Lord’s Mark Industries Shareholders Approve All 13 Resolutions at 46th AGM Lord’s Mark Industries Limited announced the voting results for its 46th AGM held on 30th Sep'26, with all 13 resolutions approved by shareholders with near-unanimous majorities. Key approvals include the adoption of FY26 audited financial statements, the reappointment of director Mr. Manav K. Teli, the appointment of M/s. Sanjeev S. Gupta & Associates as statutory auditors, enhancing borrowing limits to ₹1,000 crore under Section 180(1)(c), and approving loans, investments, and related party transactions up to ₹50 crore under Sections 185, 186, and 188.
Proceeding of AGM held on 30-09-2026
Annual General Meeting · 30 Sept 2026, 9:41 pm
AI powered dialysis update
Others (Uncategorized) · 28 Sept 2026, 2:03 pm
Lord's Mark Secures UK MHRA Registration for AI Dialysis System Lord's Mark Industries Limited secured UK MHRA registration for its AI-powered Renalyx haemodialysis system (institutional and home use under GMDN Code 58131 via manufacturer Renalyx Health Systems Pvt. Ltd.). This opens market access to the UK and UK-allied regions, with machine exports scheduled to commence in early Jan'27. The company's global expansion strategy combines equipment supply to healthcare providers with establishing its own operational dialysis centres, delivering an integrated renal-care ecosystem driven by its proprietary RenalOS clinical intelligence platform.
Intimation under regulation 30 regarding AI - Powered Breast Cancer Screening Technology towards final clinical trials
Others (Uncategorized) · 23 Sept 2026, 2:03 pm
Lord’s Mark Advances Breast Cancer Screening Tech to Final Trials Lord’s Mark Industries received Technical Committee approval to advance its AI-powered, radiation-free wearable breast cancer screening technology to final clinical trials across the US, Great Britain, and Europe, following completed India trials. Phase 2 trials targeting 98% accuracy will commence in Jan'27. Holding exclusive commercialisation rights in collaboration with C-MET, the company is pursuing CDSCO, US FDA, and European approvals. It targets trial completion by Mar'27 and a commercial launch by Apr'27, addressing a global breast cancer diagnostics market projected to reach USD 11.4B by 2033 (8.8% CAGR).
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sachidanand Hariram Upadhyay
Acquisition/ Disposal of Shares · 22 Sept 2026, 6:21 pm
Lord's Mark Industries Promoter Sells 2.43% Stake via Open Market Promoter Sachidanand Hariram Upadhyay sold 1,03,56,983 equity shares (representing a 2.43% stake) of Lord's Mark Industries Limited via open market transactions on 18th Sep'26. Following this disposal, the promoter's shareholding decreased from 33,07,96,229 equity shares (77.54%) to 32,04,39,246 equity shares (75.11%). The company's total equity base remains unchanged at 42,66,22,217 equity shares of Rs. 10 each, aggregating to Rs. 426.62 crore.
Completion of Phase I expansion at Silvassa Facility
Others (Uncategorized) · 16 Sept 2026, 3:49 pm
Lord's Mark Industries Completes Phase I Silvassa Expansion Ahead of Schedule Lord's Mark Industries completed Phase I expansion at its Silvassa facility nearly three months ahead of the Dec'26 timeline, with commercial operations scheduled to begin on 11th Oct'26. The expansion increases its surgical and orthopaedic portfolio from 36 to 54 SKUs via the addition of 18 new products. While the existing 36 SKUs already hold US FDA approval, the 18 new SKUs are currently undergoing US FDA review, with clearance anticipated before Dec'26 to support global and domestic market expansion.
Highlights of investor''s meet
Investor Presentation · 15 Sept 2026, 11:50 pm
Lord’s Mark Industries Investor Meet Presentation Highlights Lord’s Mark Industries targets rapid growth driven by its IVD/MedTech, Renalyx dialysis, and solar verticals, forecasting revenue to surge from ₹710 Cr in FY25 to ₹2,638 Cr in FY29 (~25.2% CAGR) with EBITDA margins expanding to 15.1%. The company holds a ₹2,000 Cr secured clean energy order book within a ₹3,000+ Cr pipeline. Key strategic catalysts include a ₹500 Cr FPO/preferential allotment and NSE listing in FY27, an IVD/MedTech demerger by FY28, and a targeted $3 billion group valuation by 2029.
Transcript of Investor conference call
Investor Presentation · 12 Sept 2026, 6:03 pm
Lord’s Mark Industries Outlines MedTech Expansion and Strong Multi-Year Growth Guidance Lord’s Mark Industries provided FY27 guidance projecting consolidated revenue of ₹1,550 crore with ~21% EBITDA margin and ~13.25% PAT margin, led by MedTech (₹825 crore). For FY28, revenue is targeted to cross ₹2,100 crore with EBITDA margins expanding to 23–24%. The firm plans ₹300–350 crore in capex over three years, including an IVD plant in Lucknow and in-house dialysis manufacturing. Operating cash flow is expected to turn positive in FY27. To meet MPS norms, promoters will dilute 4–5% via OFS and equity.
Audio and Video recording of Investor''s meet
Investor Presentation · 11 Sept 2026, 2:22 am
Lord's Mark Industries Discloses Audio and Video Recording of Investor Call Lord's Mark Industries Limited (BSE: 501261) announced the successful completion of its investor conference call organized by Financial Mindss on 10th Sep'26 at 04:00 PM IST. The interaction focused on reviewing the company's business progress and operational developments. In compliance with Regulations 30 and 46 of SEBI LODR Regulations, 2015, the company has made the complete audio and video recordings of the proceedings accessible to the exchange and investors through its designated digital repository.
Investor Meet update
Others (Uncategorized) · 10 Sept 2026, 2:33 am
Lord's Mark Industries to Participate in Virtual Investor Meet Lord's Mark Industries Limited has been invited to participate in a virtual Investor Meet organized by Financial Mindss (A JaiBharti Group Co.) on 10th Sep'26 at 04:00 p.m. IST. The management will engage with investors and analysts to discuss the company's business progress and operational developments.
The Board of Directors, based on the recommendation of the MPS Committee, at its meeting held on Saturday, September 5, 2026, considered and approved the proposal for an Offer for Sale ....
Others (Uncategorized) · 05 Sept 2026, 9:09 pm
Lord's Mark Industries Approves Promoter OFS of Up to 3% Lord's Mark Industries Limited's Board of Directors, based on the MPS Committee's recommendation, approved a proposal on 5th Sep'26 for an Offer for Sale (OFS) of up to 3% of the company's paid-up equity share capital by promoters. The OFS aims to comply with Minimum Public Shareholding (MPS) requirements, subject to requisite regulatory approvals and promoter consents. Authorized company officers have been empowered to execute necessary filings, disclosures, and statutory actions to complete the transaction.
ANNUAL REPORT 2025-26
Others (Uncategorized) · 05 Sept 2026, 5:07 pm